Literature DB >> 25407782

Liposomal melatonin rescues methamphetamine-elicited mitochondrial burdens, pro-apoptosis, and dopaminergic degeneration through the inhibition PKCδ gene.

Xuan-Khanh Thi Nguyen1, Jaehwi Lee, Eun-Joo Shin, Duy-Khanh Dang, Ji Hoon Jeong, Thuy-Ty Lan Nguyen, Yunsung Nam, Hyun-Jong Cho, Jae-Chul Lee, Dae Hun Park, Choon-Gon Jang, Jau-Shyong Hong, Toshitaka Nabeshima, Hyoung-Chun Kim.   

Abstract

We have demonstrated that mitochondrial oxidative damage and PKCδ overexpression contribute to methamphetamine-induced dopaminergic degeneration. Although it is recognized that antioxidant melatonin is effective in preventing neurotoxicity induced by methamphetamine, its precise mechanism remains elusive. C57BL/6J wild-type mice exhibited a similar degree of dopaminergic deficit when methamphetamine was administered during light and dark phases. Furthermore, dopaminergic neuroprotection by genetic inhibition of PKCδ during the light phase was comparable to that during the dark phase. Thus, we have focused on the light phase to examine whether melatonin modulates PKCδ-mediated neurotoxic signaling after multiple high doses of methamphetamine. To enhance the bioavailability of melatonin, we applied liposomal melatonin. Treatment with methamphetamine resulted in hyperthermia, mitochondrial translocation of PKCδ, oxidative damage (mitochondria > cytosol), mitochondrial dysfunction, pro-apoptotic changes, ultrastructural mitochondrial degeneration, dopaminergic degeneration, and behavioral impairment in wild-type mice. Treatment with liposomal melatonin resulted in a dose-dependent attenuation against degenerative changes induced by methamphetamine in wild-type mice. Attenuation by liposomal melatonin might be comparable to that by genetic inhibition (using PKCδ((-/-)) mice or PKCδ antisense oligonucleotide). However, liposomal melatonin did not show any additional protective effects on the attenuation by genetic inhibition of PKCδ. Our results suggest that the circadian cycle cannot be a key factor in modulating methamphetamine toxicity under the current experimental condition and that PKCδ is one of the critical target genes for melatonin-mediated protective effects against mitochondrial burdens (dysfunction), oxidative stress, pro-apoptosis, and dopaminergic degeneration induced by methamphetamine.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  dopamine; liposomal melatonin; methamphetamine; mitochondria; oxidative stress; pro-apoptosis; protein kinase Cδ

Mesh:

Substances:

Year:  2014        PMID: 25407782     DOI: 10.1111/jpi.12195

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  17 in total

Review 1.  Role of Mitochondria in Methamphetamine-Induced Dopaminergic Neurotoxicity: Involvement in Oxidative Stress, Neuroinflammation, and Pro-apoptosis-A Review.

Authors:  Eun-Joo Shin; Hai-Quyen Tran; Phuong-Tram Nguyen; Ji Hoon Jeong; Seung-Yeol Nah; Choon-Gon Jang; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Neurochem Res       Date:  2017-06-07       Impact factor: 3.996

2.  PKCδ-dependent p47phox activation mediates methamphetamine-induced dopaminergic neurotoxicity.

Authors:  Duy-Khanh Dang; Eun-Joo Shin; Dae-Joong Kim; Hai-Quyen Tran; Ji Hoon Jeong; Choon-Gon Jang; Ole Petter Ottersen; Seung-Yeol Nah; Jau-Shyong Hong; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Free Radic Biol Med       Date:  2017-12-18       Impact factor: 7.376

3.  PKCδ knockout mice are protected from para-methoxymethamphetamine-induced mitochondrial stress and associated neurotoxicity in the striatum of mice.

Authors:  Eun-Joo Shin; Duy-Khanh Dang; Hai-Quyen Tran; Yunsung Nam; Ji Hoon Jeong; Young Hun Lee; Kyung Tae Park; Yong Sup Lee; Choon-Gon Jang; Jau-Shyong Hong; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Neurochem Int       Date:  2016-09-10       Impact factor: 3.921

4.  N-Methyl, N-propynyl-2-phenylethylamine (MPPE), a Selegiline Analog, Attenuates MPTP-induced Dopaminergic Toxicity with Guaranteed Behavioral Safety: Involvement of Inhibitions of Mitochondrial Oxidative Burdens and p53 Gene-elicited Pro-apoptotic Change.

Authors:  Eun-Joo Shin; Yunsung Nam; Ji Won Lee; Phuong-Khue Thi Nguyen; Ji Eun Yoo; The-Vinh Tran; Ji Hoon Jeong; Choon-Gon Jang; Young J Oh; Moussa B H Youdim; Phil Ho Lee; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Mol Neurobiol       Date:  2015-11-13       Impact factor: 5.590

5.  Melatonin Protects SH-SY5Y Neuronal Cells Against Methamphetamine-Induced Endoplasmic Reticulum Stress and Apoptotic Cell Death.

Authors:  Pawaris Wongprayoon; Piyarat Govitrapong
Journal:  Neurotox Res       Date:  2016-07-01       Impact factor: 3.911

Review 6.  Methamphetamine-induced dopaminergic neurotoxicity as a model of Parkinson's disease.

Authors:  Eun-Joo Shin; Ji Hoon Jeong; Yeonggwang Hwang; Naveen Sharma; Duy-Khanh Dang; Bao-Trong Nguyen; Seung-Yeol Nah; Choon-Gon Jang; Guoying Bing; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Arch Pharm Res       Date:  2021-07-20       Impact factor: 4.946

7.  Apocynin prevents mitochondrial burdens, microglial activation, and pro-apoptosis induced by a toxic dose of methamphetamine in the striatum of mice via inhibition of p47phox activation by ERK.

Authors:  Duy-Khanh Dang; Eun-Joo Shin; Yunsung Nam; Sungwoo Ryoo; Ji Hoon Jeong; Choon-Gon Jang; Toshitaka Nabeshima; Jau-Shyong Hong; Hyoung-Chun Kim
Journal:  J Neuroinflammation       Date:  2016-01-18       Impact factor: 8.322

Review 8.  Melatonin: A Mitochondrial Targeting Molecule Involving Mitochondrial Protection and Dynamics.

Authors:  Dun-Xian Tan; Lucien C Manchester; Lilan Qin; Russel J Reiter
Journal:  Int J Mol Sci       Date:  2016-12-16       Impact factor: 5.923

Review 9.  Neurotoxicity of methamphetamine: Main effects and mechanisms.

Authors:  Subramaniam Jayanthi; Atul P Daiwile; Jean Lud Cadet
Journal:  Exp Neurol       Date:  2021-06-26       Impact factor: 5.620

10.  Combined Skin Moisturization of Liposomal Serine Incorporated in Hydrogels Prepared with Carbopol ETD 2020, Rhesperse RM 100 and Hyaluronic Acid.

Authors:  Hyeongmin Kim; Jieun Ro; Sonia Barua; Deuk Sun Hwang; Seon-Jeong Na; Ho Sung Lee; Ji Hoon Jeong; Seulki Woo; Hyewon Kim; Bomi Hong; Gyiae Yun; Joong-Hark Kim; Young-Ho Yoon; Myung-Gyu Park; Jia Kim; Uy Dong Sohn; Jaehwi Lee
Journal:  Korean J Physiol Pharmacol       Date:  2015-10-16       Impact factor: 2.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.